Pages that link to "Item:Q1662053"
From MaRDI portal
The following pages link to Optimal experimental designs for estimating the drug combination index in toxicology (Q1662053):
Displaying 11 items.
- Optimal designs for dose-finding experiments in toxicity studies (Q605849) (← links)
- Optimal designs for discriminating between dose-response models in toxicology studies (Q627292) (← links)
- Compromise design for combination experiment of two drugs (Q830471) (← links)
- A mapping-based universal kriging model for order-of-addition experiments in drug combination studies (Q830482) (← links)
- Optimum experimental designs for comparative bioavailability studies (Q1338369) (← links)
- Experimental designs for drug combination studies (Q1621390) (← links)
- Optimal adaptive designs for acute oral toxicity assessment (Q2492920) (← links)
- Experimental design for multi-drug combination studies using signaling networks (Q3119871) (← links)
- Optimal 3×3 factorial and 3-ray designs for drug interaction experiments with dichotomous responses (Q3474103) (← links)
- Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials (Q3576931) (← links)
- On the combination of <i>c</i>‐ and <i>D</i>‐optimal designs: General approaches and applications in dose–response studies (Q5347419) (← links)
